No Data
Smart Money Is Betting Big In MRK Options
Viking Speeds Development Its Weight-Loss Pill -- Barrons.com
ServiceNow Turns Heads With Impressive Results, Rev Gains on Gen-AI
Merck KGaA to Sell Surface Solutions Unit for EUR665 Million
Preventive monoclonal antibody from Merck (MRK.US) achieves positive results, used for preventing infant RSV infection.
Merck (MRK.US) announced that the investigational respiratory syncytial virus (RSV) prophylactic monoclonal antibody clesrovimab (MK-1654) has obtained positive results in phase 2b/3 clinical trials.
Acquiring the company for over 1.3 billion US dollars! Merck's (MRK.US) new small-molecule cancer drug has entered phase 3 clinical trials in China.
According to the latest announcement by China's drug clinical trial registration and information disclosure platform, Merck (MRK.US) has initiated a Phase III clinical study for a new oral drug, MK-3543 (bomedemstat), for the treatment of primary thrombocytosis.
No Data
